华海药业
(600521)
| 流通市值：271.42亿 | | | 总市值：279.09亿 |
| 流通股本：14.56亿 | | | 总股本：14.97亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,261,522,255.27 | 1,536,570,418.11 | 1,446,524,268.72 | 1,591,042,171.54 |
| 应收票据及应收账款 | 3,124,445,781.67 | 2,942,801,076.56 | 2,665,677,209.52 | 2,847,738,349.71 |
| 应收账款 | 3,124,445,781.67 | 2,942,801,076.56 | 2,665,677,209.52 | 2,847,738,349.71 |
| 应收款项融资 | 250,364,818.22 | 292,634,960.54 | 82,677,692.97 | 106,386,267.3 |
| 预付款项 | 108,063,278.49 | 94,947,808.13 | 122,890,125.92 | 101,327,402.73 |
| 其他应收款合计 | 35,352,284.11 | 38,756,794.76 | 40,584,000.37 | 22,853,008.06 |
| 存货 | 3,483,682,508.77 | 3,413,419,932.83 | 3,479,075,472.55 | 3,236,932,126.42 |
| 其他流动资产 | 106,850,229.99 | 103,227,410.59 | 71,991,565.52 | 149,490,028.22 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 9,462,382,014.62 | 8,483,148,001.25 | 7,980,130,228.56 | 8,120,384,717.03 |
| 非流动资产: | | | | |
| 长期股权投资 | 413,530,148.21 | 421,566,004.88 | 419,875,240.09 | 428,470,854.44 |
| 其他权益工具投资 | 35,149.46 | 35,149.46 | 55,361.17 | 55,361.17 |
| 其他非流动金融资产 | 403,166,173.57 | 374,573,703.43 | 367,351,780.71 | 332,506,308.19 |
| 投资性房地产 | 907,674.61 | 917,614.57 | 5,776,793.3 | 5,909,348.91 |
| 固定资产 | 6,264,157,676.11 | 6,352,548,355.83 | 6,004,219,141.62 | 5,651,088,410.65 |
| 在建工程 | 2,493,998,643.98 | 2,188,166,419.66 | 2,371,790,304 | 2,583,720,417.51 |
| 使用权资产 | 41,390,598.17 | 29,849,781.99 | 44,810,149.4 | 49,104,031.27 |
| 无形资产 | 1,185,304,020.7 | 1,196,100,759.73 | 1,214,382,635.76 | 1,209,688,062.96 |
| 开发支出 | 936,027,300.23 | 920,294,801.07 | 862,737,456.92 | 842,000,694.32 |
| 商誉 | 64,445,908.06 | 64,445,908.06 | 64,445,908.06 | 64,445,908.06 |
| 长期待摊费用 | 41,299,975.18 | 39,868,808.74 | 39,283,887.13 | 40,610,950.88 |
| 递延所得税资产 | 190,596,730.09 | 189,671,767.44 | 180,330,890.61 | 185,459,884.89 |
| 其他非流动资产 | 147,078.8 | 167,893.81 | - | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 12,035,007,077.17 | 11,778,206,968.67 | 11,575,059,548.77 | 11,393,060,233.25 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 21,497,389,091.79 | 20,261,354,969.92 | 19,555,189,777.33 | 19,513,444,950.28 |
| 流动负债: | | | | |
| 短期借款 | 2,209,870,330.56 | 2,110,004,519.44 | 1,484,714,448.9 | 1,884,683,357.81 |
| 应付票据及应付账款 | 1,641,881,354.23 | 1,585,053,674.5 | 1,562,779,661.44 | 1,525,868,158.38 |
| 其中：应付票据 | 566,939,330.8 | 594,790,551.8 | 508,509,424.16 | 452,720,174.66 |
| 应付账款 | 1,074,942,023.43 | 990,263,122.7 | 1,054,270,237.28 | 1,073,147,983.72 |
| 合同负债 | 46,267,656.15 | 54,403,367.82 | 40,063,972.94 | 34,733,556.6 |
| 应付职工薪酬 | 186,097,234.8 | 307,573,163.88 | 164,425,997.67 | 157,624,036.59 |
| 应交税费 | 99,639,125.96 | 167,895,781.32 | 117,812,207.8 | 120,129,217.14 |
| 其他应付款合计 | 863,954,134.72 | 789,074,374.91 | 926,780,292.91 | 953,950,414.62 |
| 一年内到期的非流动负债 | 795,384,087.08 | 957,578,820.08 | 1,384,717,816.9 | 1,034,253,209.34 |
| 其他流动负债 | 2,464,468.15 | 4,079,400.44 | 2,474,787.51 | 2,203,645.68 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 5,845,558,391.65 | 5,975,663,102.39 | 5,683,769,186.07 | 5,713,445,596.16 |
| 非流动负债: | | | | |
| 长期借款 | 2,780,060,790 | 2,511,674,048 | 2,151,225,000 | 2,079,850,000 |
| 应付债券 | 1,905,625,119.01 | 1,882,139,923.12 | 1,886,054,610.51 | 1,862,873,196.95 |
| 租赁负债 | 27,699,206.83 | 16,994,294.78 | 34,306,112.51 | 37,969,178.84 |
| 长期应付款 | 201,835,616.44 | - | - | - |
| 预计负债 | 147,863,155.57 | 152,124,694.63 | 156,247,825.2 | 160,995,317.74 |
| 递延收益 | 682,334,822.3 | 698,947,006.09 | 684,860,824.36 | 690,230,164.31 |
| 其他非流动负债 | 3,777,750 | 3,777,750 | 3,777,750 | 3,777,750 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 5,749,196,460.15 | 5,265,657,716.62 | 4,916,472,122.58 | 4,835,695,607.84 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 11,594,754,851.8 | 11,241,320,819.01 | 10,600,241,308.65 | 10,549,141,204 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,507,907,834 | 1,466,755,454 | 1,466,755,454 | 1,466,755,454 |
| 其他权益工具 | 240,134,436.12 | 240,134,957.47 | 240,135,087.81 | 240,135,087.81 |
| 资本公积 | 1,727,518,583.01 | 1,185,423,987.85 | 1,174,057,932.36 | 1,169,994,899.11 |
| 减:库存股 | 300,046,387.8 | 300,046,387.8 | 300,046,387.8 | 300,046,387.8 |
| 其他综合收益 | 1,892,776.98 | 1,164,971.67 | -4,943,616.19 | 1,717,863.83 |
| 专项储备 | 3,261,647.15 | 3,169,676.53 | 3,103,568.63 | 3,327,010.85 |
| 盈余公积 | 745,795,769.54 | 745,795,769.54 | 745,795,769.54 | 745,795,769.54 |
| 未分配利润 | 5,852,784,935.43 | 5,555,380,857.68 | 5,467,667,815.52 | 5,474,780,731.08 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 9,779,249,594.43 | 8,897,779,286.94 | 8,792,525,623.87 | 8,802,460,428.42 |
| 少数股东权益 | 123,384,645.56 | 122,254,863.97 | 162,422,844.81 | 161,843,317.86 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 9,902,634,239.99 | 9,020,034,150.91 | 8,954,948,468.68 | 8,964,303,746.28 |
| 负债和股东权益合计 | 21,497,389,091.79 | 20,261,354,969.92 | 19,555,189,777.33 | 19,513,444,950.28 |
| 公告日期 | 2025-04-30 | 2025-04-30 | 2024-10-31 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |